The forecasted sold production of medicaments containing corticosteroid hormones in Italy shows a steady decline from 2024 to 2028, with values starting at 424.41 million Euros in 2024 and dropping to 380.46 million Euros in 2028. This represents a year-on-year decrease of roughly 3% on average. As of 2023, the sold production value stood higher, emphasizing the downward trend expected over the forecast period.
Future trends to watch for include:
- Potential impacts of healthcare policy changes on pharmaceutical pricing.
- Increasing competition from generic drug manufacturers.
- Technological advancements potentially leading to innovative, alternative therapies.
